Wallace Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,175
| Closed | -$2.26M | – | 84 |
|
|
2023
Q2 | $2.26M | Buy |
+22,175
| New | +$2.26M | 0.35% | 36 |
|
|
2019
Q3 | – | Sell |
-7,255
| Closed | -$685K | – | 70 |
|
|
2019
Q2 | $685K | Sell |
7,255
-500
| -6% | -$47.2K | 0.09% | 44 |
|
|
2019
Q1 | $663K | Hold |
7,755
| – | – | 0.09% | 43 |
|
|
2018
Q4 | $435K | Hold |
7,755
| – | – | 0.06% | 48 |
|
|
2018
Q3 | $634K | Buy |
7,755
+5
| +0.1% | +$409 | 0.08% | 47 |
|
|
2018
Q2 | $271K | Buy |
+7,750
| New | +$271K | 0.04% | 63 |
|